In line with this, the anti-tumor and anti-metastatic effects of the ALDH inhibitor N,N-diethylaminobenzaldehyde were shown to be enhanced by administration at the time of day when ALDH activity was high in 4T1 breast cancer stem cells that produce tumors in mice [120]. Here, LDHA is linked to breast cancer.